An Investigation of the Inverted Structure of a PBDB:T/PZT:C1-Based Polymer Solar Cell

Based on experimental results, this theoretical study presents a new approach for investigating polymers' solar cells. P-type PZT:C1 and N-type PBDB:T were used to construct a blend for use as a photoactive layer for the proposed all-polymer solar cell. Initially, an architecture of an ITO/PEDOT:PSS/PBDB:T/PZT:C1/PFN-Br/Ag all-polymer solar device calibrated with experimental results achieved a PCE of 14.91%. A novel inverted architecture of the same solar device, proposed for the first time in this paper, achieved a superior PCE of 19.92%. Furthermore, the optimization of the doping of the transport layers is proposed in this paper. Moreover, the defect density and the thickness of the polymer are studied, and a PCE of 22.67% was achieved by the optimized cell, which is one of the highest PCEs of polymer solar devices. Finally, the optimized polymer solar cell showed good stability amidst temperature variations. This theoretical study sheds light on the inverted structure of all-polymer solar devices.

Modulation of DNA damage response by targeting ATM kinase using newly synthesized di-phenoxy acetamide (DPA) analogs to induce anti-neoplasia

BACKGROUND

Imbalance and instability in the structure of the DNA have become major characteristics of cancer. In response to DNA damage, DNA damage response (DDR) protein, ataxia telangiectasia mutated (ATM), plays a pivotal role in the modulation of regulatory regions responsible for inhibition of apoptosis, thereby neoplastic progression.

METHODS

A new series of DPA (7a-t) were synthesized, characterized. Anti-proliferative studies to identify the lead compound were carried out by LDH and MTT assay. Apoptosis/DNA damage was measured through FACS, Annexin-v staining, TUNEL and Comet assay. Elucidation of molecular mechanism through immunoblot and further validation of the drug effect through in vivo approaches.

RESULTS

Initial in vitro anti-proliferative screening of Compounds DPA (7a-t) against multiple cancer cell lines identified Compound DPA (7n) as a potent cytotoxic molecule with IC₅₀ value of 4.3 μM. Down the line, in vitro and in vivo evaluation of Compound DPA (7n) inferred that it has apoptotic inducing potentiality. Further, evaluation of molecular mechanism inferred that Compound DPA (7n) effectively modulates ATM phosphorylation only, eventually altering downstream signalling pathways.

CONCLUSIONS

Compound DPA (7n) emerged as a potent proapoptotic and anti-neoplastic agent by inhibiting ATM kinase activity both in vitro and in vivo. The conferring results ascertain that the drug could be developed as a new ATM kinase inhibitor with anti-cancer capacity.